DaVita Income Lower in Q1
DaVita reported income for Q1 of 2017 was 21 percent less than the same time last year. The drop in income was attributed to lower ACA enrollment among dialysis patients, an increase in wages for clinical staff and adjusted operating income for pharmacy operations.
Source: Nephrology News & Issues
DaVita Names Dr. George R. Arnoff VP of Clinical Affairs
Dr. George Arnoff will serve as VP Clinical Affairs for the company’s hemodialysis operations and also will be a member of the Office of the Chief Medical Officer on DaVita Kidney Care’s physician leadership team. Previously, Arnoff served as the chief medical officer of Renal Ventures Management, which DaVita acquired in May.
Source: Nephrology News & Issues
Fresenius Medical Care’s Q1 Income Grows
Fresenius Medical Care’s Q1 income grew 17 percent. The company’s North American revenue, which represents 74 percent of its total revenue, grew 18 percent.
Source: Nephrology News & Issues
Early Hospital Readmission Associated with Higher Mortality
A study in Kidney International found that hemodialysis patients had a higher risk of death — regardless of the timing — if they were readmitted within one year of their discharge date.
Source: Kidney International
ESRD Risk is Higher Among Kidney Donors Who are Living Black Males
Living kidney donors who are black males are at an increased risk for developing end-stage renal disease (ESRD), researchers found. Among non-black living donors, older age of the donor was associated with an increased risk of developing ESRD.
Source: Renal & Urology News
Nephrology Fellowship Teaching Gets High Ratings
Many nephrology fellows rate the quality of their teaching as good or excellent, with second-year fellows saying they feel fully equipped to enter independent practice. Fellows reported using UpToDate, JASN/CJASN, and NephSAP as frequent resources.
Source: Renal & Urology News
Complications from Hospital-Acquired Infections Deadly for CKD Patients
Researchers found that CKD patients with at least one preventable hospital-acquired infection faced increased risk of death, risk of readmission or incremental length of stays.
Source: Renal & Urology News
